IV Therapy and Vein Access Devices Market 2022 | Scope of Current and Future Industry 2032
The global IV therapy and vein access devices market is estimated to garner US$ 44.4 Billion while exhibiting a 5.6% CAGR during the forecast period, concludes a recently published report by Future Market Insights. The growing support from several governments is likely to fuel the market growth in the coming years. The industry is expected to secure US$ 25.8 Billion in 2022.
Increasing expenditure on healthcare, growing awareness about healthcare procedures, and an increasing number of specialty clinics and ambulatory centres will further expand the size of the IV therapy and vein access devices market in the future.
As per the analysis, the medical administration segment is anticipated to hold remunerative opportunities for the global IV therapy and vein access devices market. Various developing countries are making significant developments in their budgets, thereby, offering lucrative opportunities to players in the market.
Key Takeaways from the Market Study
- Based on type, intravenous catheters are expected to record a 5.5% CAGR by 2032
- By medical application, the medical administration segment to expand at a 5.6% growth rate during the forecast period
- The U.S market to garner US$ 15.9 Billion and record a 5.4% CAGR from 2022–2032
- Market in China to procure US$ 3.2Billion, expanding at a 4.9% growth rate during the assessment period
Competitive Landscape
Eminent players of the global IV Therapy and Vein Access Devices Market include Becton, Dickinson and Company, B. Braun Holding Gmbh & Co. Kg, Terumo Medical Corporation, Teleflex Medical Inc., and Medtronic Inc. among others. Recent key developments among players include:
- In Feb-2022 — BD (Becton, Dickinson and Company) announced its acquisition of Cytognos, a privately held company headquartered in Salamanca, Spain, specializing in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection and immune monitoring research for blood diseases.
- In January 2021, Teleflex releases the Arrow® ErgoPack® Complete Multi-LumenAccessCatheter (MAC) System and the Arrow® ErgoPack® Complete Percutaneous Sheath Introducer (PSI) System. High-flow Arrow® MAC Catheters are designed to meet the needs of a variety of patient types — from trauma to cardiac — and offer full-spectrum antimicrobial protection against gram-positive, and gram-negative bacteria and fungi, the key infectious pathogens responsible for CLABSI.
Information Source:
https://www.futuremarketinsights.com/reports/iv-therapy-and-vein-access-devices-market
Comments
Post a Comment